PCSK9 inhibitor (class)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PCSK9 inhibitor (class), covering 2024-04-30 to 2024-04-30. Get the full timeline:
Most recent: Clinical Trial Update: PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS [Phase 2]